Shoulder Impingement, Shoulder Impingement Syndrome, Shoulder Pain, Subacromial Impingement, Subacromial Impingement Syndrome
Conditions
Brief summary
This randomized clinical trial aims to compare the efficacy of corticosteroid injection and tendon dry needling for the treatment of subacromial impingement syndrome.
Detailed description
This randomized clinical trial will compare the efficacy of corticosteroid injection and tendon dry needling for the treatment of subacromial impingement syndrome.Participants will be randomized to receive either a corticosteroid injection or tendon dry needling treatment. The corticosteroid injection group will receive a single subacromial injection of 40mg triamcinolone acetonide under ultrasound guidance. The tendon dry needling group will receive a total of 3 sessions of dry needling treatment to the supraspinatus, infraspinatus, and subscapularis muscle tendons. Patients will be assessed before treatment, after treatment, after three weeks and after three months with visual analog scale, Shoulder Pain and Disability Index (SPADI) and shoulder range of motion measurements.
Interventions
PROCEDURECorticosteroid injection
Subacromial injection of 40mg triamcinolone acetonide.
PROCEDUREDry Needling
Dry needling treatment to the supraspinatus, infraspinatus, and subscapularis muscles tendons.
Sponsors
Uskudar State Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Masking description
The outcomes assessor will be blinded.
Intervention model description
Randomized controlled trial
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Adult patients aged 18-65 years old * Diagnosis of subacromial impingement syndrome, confirmed by clinical examination and imaging (such as X-ray or MRI) * Moderate to severe shoulder pain, with a score of at least 4 on a 0-10 visual analog scale (VAS) for pain * Willingness to comply with the study protocol and attend all study visits and assessments * Ability to provide informed consent to participate in the study.
Exclusion criteria
* Contraindications to corticosteroid injection or dry needling, such as local infection, bleeding disorders, or allergy to the injectate or needle * Previous shoulder surgery on the affected shoulder * Other active shoulder conditions, such as rotator cuff tear or adhesive capsulitis, that may confound the study results * Systemic conditions, such as rheumatoid arthritis or osteoarthritis, that may affect the shoulder joint and its function * History of shoulder dislocation or instability * Pregnancy or breastfeeding * Current use of systemic corticosteroids or immunosuppressive drugs * Injection to shoulder area in the past six months. * Inability to complete the study assessments or follow the study protocol, such as due to cognitive impairment or language barrier.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Visual Analog Scale for Pain | First day, after three weeks, after three months | A Visual Analog Scale (VAS) for pain is a commonly used tool to measure the intensity of pain experienced by a patient. It typically consists of a horizontal or vertical line, typically 10 centimeters long, with endpoints labeled as no pain and worst possible pain. The patient is asked to mark on the line the point that best represents the intensity of their pain, with the distance from the no pain end of the line to the patient's mark representing the pain score. |
| Change in The Shoulder Pain and Disability Index (SPADI) | First day, after three weeks, after three months | The Shoulder Pain and Disability Index (SPADI) is a validated patient-reported outcome measure that is commonly used to assess pain and functional disability related to shoulder disorders. The SPADI consists of 13 items that assess pain and disability in two domains: 1) pain and 2) disability. The pain domain consists of five items that assess the intensity and frequency of shoulder pain, while the disability domain consists of eight items that assess the impact of shoulder pain on daily activities such as sleeping, dressing, and carrying objects. |
| Change in Range Of Motion (ROM) Measurements | First day, after three weeks, after three months | ROM of the shoulder joint is typically assessed using a goniometer, a device that measures joint angles. The goniometer is used to measure the degree of movement in different directions, including flexion, extension, abduction, adduction, internal rotation, and external rotation. The measurements obtained from the goniometer can then be used to determine the improvement or deterioration in ROM over time, which can be an indicator of treatment efficacy. |
Contacts
Primary ContactMustafa H Temel, M.D.
Backup ContactFatih Bağcıer, M.D.
Outcome results
None listed